Effects of enalaprilat on neointimal growth of cultured rabbit aorta following balloon injury

Canadian Journal of Physiology and Pharmacology

Volumn 77, Issue 10, 1999, Pages 763-769

  Dale, William E ^a   Blaine, Edward H ^a  

^a UNIVERSITY OF MISSOURI   (United States)

Author keywords

Angiotensin; Angiotensin converting enzyme inhibitors; Aorta; Organ culture; Restenosis

Indexed keywords

ENALAPRILAT;

ANIMAL TISSUE; AORTA INJURY; ARTICLE; BLOOD VESSEL INJURY; CELL PROLIFERATION; CONTROLLED STUDY; DRUG EFFECT; DRUG TISSUE LEVEL; INTIMA; MALE; NONHUMAN; PERCUTANEOUS TRANSLUMINAL ANGIOPLASTY; PRIORITY JOURNAL; RABBIT;

EID: 0033428250     PISSN: 00084212     EISSN: None     Source Type: Journal    
DOI: 10.1139/y99-062     Document Type: Article

References (53)

1. Al-Merani, S. A., Brooks, D.P., Chapman, B. J., and Munday, K. A. 1978. The half-lives of angiotensin II, angiotensin II-amide, angiotensin III, Sarl-Ala8-angiotensin II and renin in the circulatory system of the rat. J. Physiol. (London), 278: 471-490.
2. Ambrosioni, E., Bacchelli, S., Degli Esposti, D., and Borghi, C. 1993. Ace-inhibitors and experimental atherosclerosis. Clin. Exp. Hypertens. 15(Suppl. 1): 157-172.
3. Bell, F.R., Doris, P.A., and Wood, T.J. 1985. The coincidental effects of dehydration and rehydration on plasma and cerebrospinal fluid angiotensin II levels in unrestrained steers. Brain Res. 325: 143-150.
4. Boonen, H.C., Schiffers, P.M., Fazzi, G.E., Janssen, G.M., Daemen, M.J., and De Mey, J.G. 1991. DNA synthesis in isolated arteries. Kinetics and structural consequences. Am. J. Physiol. 260: H210-H217.
5. Campbell, D.J. 1987. Tissue renin-angiotensin system: sites of angiotensin formation. J. Cardiovasc. Pharmacol. 10(Suppl. 7): S1-S8.
6. Campbell, D.J., and Habener, J.F. 1986. Angiotensinogen gene is expressed and differentially regulated in multiple tissues of the rat. J. Clin. Invest. 78: 31-39.
7. Campbell, J.H., Tachas, G., Black, M.J., Cockerill, G., and Campbell, G.R. 1991. Molecular biology of vascular hypertrophy. Basic Res. Cardiol. 86(Suppl. 1): 3-11.
8. Campbell, J.H., Fennessy, P., and Campbell, G.R. 1992. Effect of perindopril on the development of atherosclerosis in the cholesterol-fed rabbit. Clin. Exp. Pharmacol. Physiol. Suppl. 19: 13-17.
9. Chapman, B.J., Brooks, D.P., and Munday, K.A. 1980. Half-life of angiotensin II in the conscious and barbiturate-anaesthetized rat. Br. J. Anaesth. 52: 389-393.
10. Cheng, J.W., and Ngo, M.N. 1997. Current perspective on the use of angiotensin-converting enzyme inhibitors in the management of coronary (atherosclerotic) artery disease. Ann. Pharmacother. 31: 1499-1506.
11. Chobanian, A.V., Hope, S., and Brecher, P. 1995. Dissociation between the antiatherosclerotic effect of trandolapril and suppression of serum and aortic angiotensin-converting enzyme activity in the Watanabe heritable hyperlipidemic rabbit. Hypertension (Dallas), 25: 1306-1310.
12. Clozel, J.P., Hess, P., Michael, C., Schietinger, K., and Baumgartner, H.R. 1991. Inhibition of converting enzyme and neointima formation after vascular injury in rabbits and guinea pigs. Hypertension (Dallas), 18(4 Suppl.): II55-II59.
13. Clozel, J.P., Hess, P., Schietinger, K., Breu, V., Fischli, W., and Baumgartner, H.R. 1994. Major role of the renin angiotensin system in the neointima formation after vascular injury in guinea pigs. Life Sci. 54: L87-L92.
14. Cunningham, D.F, and O'Connor, B. 1997. Identification and initial characterisation of a N-benzyloxycarbonyl-prolyl-prolinal (Z-Pro-prolinal)-insensitive 7-(N-benzyloxycarbonyl-glycyl-prolyl-amido)-4-methylcoumarin (Z-Gly-Pro-NH-Mec)-hydrolysing peptidase in bovine serum. Eur. J. Biochem. 244: 900-903.
15. Dale, W.E., Batra, P.S., and Blaine, E.H. 1998. Enhanced neointimal growth in cultured rabbit aorta following in vivo balloon angioplasty. In Vitro Cell. Dev. Biol. Anim. 34: 805-812.
16. Davies, M.G., Klyachkin, M.L., Barber, L., Svendsen, E., and Hagen, P.O. 1995. Ramipril and experimental vein graft intimal hyperplasia. Angiology, 46: 91-97.
17. Dusting, G.J., Hyland, R., Hickey, H., and Makdissi, M. 1995. Angiotensin-converting enzyme inhibitors reduce neointimal thickening and maintain endothelial nitric oxide function in rabbit carotid arteries. Am. J. Cardiol. 76: 24E-27E.
18. Dzau, V.J. 1984. Vascular renin-angiotensin: a possible autocrine or paracrine system in control of vascular function. J. Cardiovasc. Pharmacol. 6(Suppl. 2): S377-S382.
19. Dzau, V.J. 1988. Circulating versus local renin-angiotensin system in cardiovascular homeostasis. Circulation, 77: I4-I13.
20. Dzau, V.J. 1993. Vascular renin-angiotensin system and vascular protection. J. Cardiovasc. Pharmacol. 22(Suppl. 5): S1-S9.
21. Farhy, R.D., Carretero, O.A., Ho, K.L., and Scicli, A.G. 1993. Role of kinins and nitric oxide in the effects of angiotensin converting enzyme inhibitors on neointima formation. Circ. Res. 72: 1202-1210.
22. Fennessy, P.A., Campbell, J.H., and Campbell, G.R. 1994a. An angiotensin converting enzyme inhibitor, perindopril, prevents progression of preformed atheresclerotic lesions in the cholesterol-fed rabbit. Clin. Sci. 87: 685-691.
23. Fennessy, P.A., Campbell, J.H., and Campbell, G.R. 1994b. Perindopril inhibits both the development of atherosclerosis in the cholesterol-fed rabbit and lipoprotein binding to smooth muscle cells in culture. Atherosclerosis, 106: 29-41.
24. George, S.J., Williams, A., and Newby, A.C. 1996. An essential role for platelet-derived growth factor in neointima formation in human saphenous vein in vitro. Atherosclerosis, 120: 227-240.
25. Grantham, J.A., Schirger, J.A., Williamson, E.E., Heublein, D.M., Wennberg, P.W., Kirchengast, M., Muenter, K., Subkowski, T., and Burnett, J.C., Jr. 1998. Enhanced endothelin-converting enzyme immunoreactivity in early atherosclerosis. J. Cardiovasc. Pharmacol. 31(Suppl. 1): S22-S26.
26. Hanke, H., Strohschneider, T., Oberhoff, M., Betz, E., and Karsch, K.R. 1990. Time course of smooth muscle cell proliferation in the intima and media of arteries following experimental angioplasty. Circ. Res. 67: 651-659.
27. Hanson, S.R., Powell, J.S., Dodson, T., Lumsden, A., Kelly, A.B., Anderson, J.S., Clowes, A.W, and Harker, L.A. 1991. Effects of angiotensin converting enzyme inhibition with cilazapril on intimal hyperplasia in injured arteries and vascular grafts in the baboon. Hypertension (Dallas), 18(4 Suppl.): II70-II76.
28. Hernandez-Presa, M., Bustos, C., Ortego, M., Tunon, J., Renedo, G., Ruiz-Ortega, M., and Egido, J. 1997. Angiotensin-converting enzyme inhibition prevents arterial nuclear factor-kappa B activation, monocyte chemoattractant protein-1 expression, and macrophage infiltration in a rabbit model of early accelerated atherosclerosis. Circulation, 95: 1532-1541.
29. Heyndrickx, G.R. 1993. Angiotensin-converting enzyme inhibitor in a human model of restenosis. MERCATOR ("Multicenter European research trial with cilazapril after angioplasty to prevent transluminal coronary obstruction and restenosis") Study Group. Basic Res. Cardiol. 88(Suppl. 1): 169-182.
30. Hickey, H., Makdissi, M., Hyland, R., Wilks, D., and Dusting, G.J. 1996. Perindopril treatment prevents the loss of endothelial nitric oxide function and development of neo-intima in rabbits. J. Mol. Cell. Cardiol. 28: 1985-1994.
31. Huber, K.C., Schwartz, R.S., Edwards, W.D., Camrud, A.R., Bailey, K.R., Jorgenson, M.A., and Holmes, D.R., Jr. 1993. Effects of angiotensin converting enzyme inhibition on neointimal proliferation in a porcine coronary injury model. Am. Heart J. 125: 695-701.
32. Kamide, K., Hori, M.T., Zhu, J.H., Barrett, J.D., Eggena, P., and Tuck, M.L. 1998. Insulin-mediated growth in aortic smooth muscle and the vascular renin-angiotensin system. Hypertension (Dallas), 32: 482-487.
33. Katz, S.A., Opsahl, J.A., Forbis, L.M., and Ayenew, W. 1996. Active renin and renin glycoform dynamics in the carotid artery. Am. J. Physiol. 271: H184-H191.
34. Lam, J.Y., Lacoste, L., and Bourassa, M.G. 1992. Cilazapril and early atherosclerotic changes after balloon injury of porcine carotid arteries. Circulation, 85: 1542-1547.
35. Lant, A.F., McNabb, R.W., and Noormohamed, F.H. 1984. Kinetic and metabolic aspects of enalapril action. J. Hypertens. 2(Suppl.): S37-S42.
36. Law, M.M., Colburn, M.D., Hajjar, G.E., Gelabert, H.A., Quinones-Baldrich, W.J., and Moore, W.S. 1994. Suppression of intimal hyperplasia in a rabbit model of arterial balloon injury by enalaprilat but not dimethyl sulfoxide. Ann. Vasc. Surg. 8: 158-165.
37. Li, J., and Wanchun, C. 1997. Benazepril on tissue angiotensin-converting enzyme and cellular proliferation in restenosis after experimental angioplasty. J. Cardiovasc. Pharmacol. 30: 790-797.
38. Luoma, J.S., Stralin, P., Marklund, S.L., Hiltunen, T.P., Sarkioja, T., and Yla-Herttuala, S. 1998. Expression of extracellular SOD and iNOS in macrophages and smooth muscle cells in human and rabbit atherosclerotic lesions: colocalization with epitopes characteristic of oxidized LDL and peroxynitrite-modified proteins. Arterioscler. Thromb. Vasc. Biol. 18: 157-167.
39. Mentlein, R., and Roos, T. 1996. Proteases involved in the metabolism of angiotensin II, bradykinin, calcitonin gene-related peptide (CGRP), and neuropeptide Y by vascular smooth muscle cells. Peptides, 17: 709-720.
40. Merrilees, M.J., Campbell, J.H., Spanidis, E., and Campbell, G.R. 1990. Glycosaminoglycan synthesis by smooth muscle cells of differing phenotype and their response to endothelial cell conditioned medium. Atherosclerosis, 81: 245-254.
41. Moore, D.D. 1992. Preparation and analysis of DNA. In Short protocols in molecular biology. A compendium of methods from Current Protocols in Molecular Biology. Edited by F.M. Ausubel, R. Brent, R.E. Kingston, D.D. Moore, J.G. Seidman, J.A. Smith, and K. Struhl. John Wiley & Sons, New York. pp. 2.1-2.38.
42. Moroi, M., Akatsuka, N., Fukazawa, M., Hara, K., Ishikawa, M., Aikawa, J., Namiki, A., and Yamaguchi, T. 1994. Endothelium-dependent relaxation by angiotensin-converting enzyme inhibitors in canine femoral arteries. Am. J. Physiol. 266: H583-H589.
43. Powell, J.S., Clozel, J.P., Muller, R.K., Kuhn, H., Hefti, F., Hosang, M., and Baumgartner, H.R. 1989. Inhibitors of angiotensin-converting enzyme prevent myointimal proliferation after vascular injury. Science (Washington, D.C.), 245: 186-188.
44. Powell, J.S., Muller, R.K., and Baumgartner, H.R. 1991. Suppression of the vascular response to injury: the role of angiotensin-converting enzyme inhibitors. J. Am. Coll. Cardiol. 17: 137B-142B.
45. Rakugi, H., Kim, D.K., Krieger, J.E., Wang, D.S., Dzau, V.J., and Pratt, R.E. 1994. Induction of angiotensin converting enzyme in the neointima after vascular injury. Possible role in restenosis. J. Clin. Invest. 93: 339-346.
46. Riezebos, J., Vleeming, W., Beems, R.B., van Amsterdam, J.G., Meijer, G.W., de, Wildt, D.J., Porsius, A.J., and Wemer, J. 1994. Comparison of the antiatherogenic effects of isradipine and ramipril in cholesterol-fed rabbits. II. Effect on regression of atherosclerosis and restoration of endothelial function. J. Cardiovasc. Pharmacol. 23: 424-431.
47. Ross, R. 1993. Atherosclerosis: a defense mechanism gone awry. Am. J. Pathol. 143: 987-1002.
48. Schiffers, P.M., Struyker-Boudier, H.A., and De Mey, J.G. 1991. Effects of angiotensin II and angiotensin converting enzyme inhibitors on contractile and growth responses in isolated carotid arteries of the rat. Basic Res. Cardiol. 86(Suppl. 1): 83-89.
49. Schuh, J.R., Blehm, D.J., Frierdich, G.E., McMahon, E.G., and Blaine, E.H. 1993. Differential effects of renin-angiotensin system blockade on atherogenesis in cholesterol-fed rabbits. J. Clin. Invest. 91: 1453-1458.
50. Stevens, A. 1990. The haematoxylins. In Theory and practice of histological techniques. Edited by J.D. Bancroft and A. Stevens. Churchill Livingstone, New York. pp. 107-118.
51. Su, C.L. and Austic, R.E. 1998. The utilization of dipeptides containing L-arginine by chicken macrophages. Poultry Sci. 77: 1852-1857.
52. Van Belle, E., Vallet, B., Auffray, J.L., Bauters, C., Hamon, M., McFadden, E.P., Lablanche, J.M., Dupuis, B., and Bertrand, M.E. 1996. NO synthesis is involved in structural and functional effects of ACE inhibitors in injured arteries. Am. J. Physiol. 270: H298-H305.
53. Zar, J.H. 1974. Biostatistical analysis. 1st ed. Prentice-Hall Inc., Englewood Cliffs, N.J. pp. 1-620.